Merck KGaA (OTCMKTS:MKGAF – Get Free Report) fell 5.3% during mid-day trading on Monday . The stock traded as low as $155.0850 and last traded at $155.0850. 178 shares traded hands during mid-day trading, a decline of 73% from the average session volume of 650 shares. The stock had previously closed at $163.7780.
Merck KGaA Stock Performance
The firm has a market capitalization of $20.04 billion, a price-to-earnings ratio of 23.68 and a beta of 0.96. The company has a debt-to-equity ratio of 0.27, a current ratio of 1.31 and a quick ratio of 0.84. The firm has a 50 day moving average price of $138.62 and a 200-day moving average price of $141.68.
Merck KGaA Company Profile
Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.
The company’s operations are organized mainly into three businesses.
Read More
- Five stocks we like better than Merck KGaA
- 3 Stocks With Fresh Catalysts to Watch Before the July 4
- Amprius Insiders Are Selling: Should Investors Be Worried?
- A Weaker Dollar Could Put These 3 Industrial Stocks Back in Focus
- A Market Rotation Toward Quality Will Benefit These 3 ETFs
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
